Use of bone morphogenetic proteins (BMPs) for the treatment of pseudarthroses - Efficiency and therapy failure;Einsatz der Bone morphogenetic Proteins (BMPs) zur Behandlung von Pseudarthrosen - Effizienz und Therapieversagen

Zeitschrift fur Orthopadie und Unfallchirurgie

Volumn 152, Issue 2, 2014, Pages 144-151

  Hausmann, M ^a   Ehnert, S ^a   Hofmann, V ^a   Dobele S ^a   Freude, T ^a   Stockle U ^a   Nussler, A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

BMP; pseudarthroses; Smad; TGF beta; treatment

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

ANIMAL; BIOLOGICAL MODEL; BONE DEVELOPMENT; DRUG EFFECTS; EVIDENCE BASED MEDICINE; FRACTURE HEALING; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSEUDARTHROSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

ANIMALS; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; EVIDENCE-BASED MEDICINE; FRACTURE HEALING; HUMANS; MODELS, BIOLOGICAL; PSEUDARTHROSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84899528119     PISSN: 18646697     EISSN: 18646743     Source Type: Journal    
DOI: 10.1055/s-0034-1368208     Document Type: Article

References (61)

1. Strohm P. C., Bannasch H., Helwig P. et al. Offene Fraktur und Weichteilschaden. Z Orthop Unfall: 2010; 148 95 112
2. Govender S., Csimma C., Genant H. K. et al. Recombinant human bone morphogenetic protein2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am: 2002; 84 2123 2134 (Pubitemid 35417689)
3. Chen G., Deng C., Li Y. P. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci: 2012; 8 272 288
4. Kang Q., Sun M., Cheng H. et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther: 2004; 11 1312 1320 (Pubitemid 39213996)
5. Ehnert S., Baur J., Schmitt A. et al. TGF-beta1 as possible link between loss of bone mineral density and chronic inflammation. PLoS One: 2010; 5 e14073
6. Dobele S., Horn C., Eichhorn S. et al. The dynamic locking screw (DLS) can increase interfragmentary motion on the near cortex of locked plating constructs by reducing the axial stiffness. Langenbecks Arch Surg: 2010; 395 421 428
7. Perren S. M., Perren T., Schneider E. Biologie und Osteosynthese - Ein Widerspruch? Ther Umsch: 2003; 60 713 721
8. Wozney J. M., Rosen V., Celeste A. J. et al. Novel regulators of bone formation: molecular clones and activities. Science: 1988; 242 1528 1534 (Pubitemid 19023695)
9. Rosen V. BMP and BMP inhibitors in bone. Ann N Y Acad Sci: 2006; 1068 19 25 (Pubitemid 43824133)
10. Breitbart A. S., Grande D. A., Mason J. M. et al. Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann Plast Surg: 1999; 42 488 495 (Pubitemid 29218313)
11. Fukunaga K., Minoda Y., Iwakiri K. et al. Early biological fixation of porous implant coated with paste-retaining recombinant bone morphogenetic protein 2. J Arthroplasty: 2012; 27 143 149
12. Sumner D. R., Turner T. M., Urban R. M. et al. Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. J Orthop Res: 2004; 22 58 65 (Pubitemid 38035446)
13. Thorey F., Menzel H., Lorenz C. et al. Enhancement of endoprosthesis anchoring using BMP-2. Technol Health Care: 2010; 18 217 229
14. Thorey F., Menzel H., Lorenz C. et al. Osseointegration by bone morphogenetic protein-2 and transforming growth factor beta2 coated titanium implants in femora of New Zealand white rabbits. Indian J Orthop: 2011; 45 57 62
15. Schmidmaier G., Wildemann B., Cromme F. et al. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone: 2002; 30 816 822 (Pubitemid 34616007)
16. Itoh S., Matubara M., Kawauchi T. et al. Enhancement of bone ingrowth in a titanium fiber mesh implant by rhBMP-2 and hyaluronic acid. J Mater Sci Mater Med: 2001; 12 575 581 (Pubitemid 32682112)
17. Woo B. H., Fink B. F., Page R. et al. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharm Res: 2001; 18 1747 1753 (Pubitemid 34020432)
18. Little D. G., McDonald M., Bransford R. et al. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model. J Bone Miner Res: 2005; 20 2044 2052 (Pubitemid 41532790)
19. Pluhar G. E., Turner A. S., Pierce A. R. et al. A comparison of two biomaterial carriers for osteogenic protein-1 (BMP-7) in an ovine critical defect model. J Bone Joint Surg Br: 2006; 88 960 966 (Pubitemid 44057189)
20. Patel Z. S., Young S., Tabata Y. et al. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone: 2008; 43 931 940
21. Donati D., Di Bella C., Lucarelli E. et al. OP-1 application in bone allograft integration: preliminary results in sheep experimental surgery. Injury: 2008; 39 65 72
22. Wildemann B., Lange K. et al. Strobel C - et al. Local BMP-2 application can rescue the delayed osteotomy healing in a rat model. Injury: 2011; 42 746 752
23. Notodihardjo F. Z., Kakudo N., Kushida S. et al. Bone regeneration with BMP-2 and hydroxyapatite in critical-size calvarial defects in rats. J Craniomaxillofac Surg: 2012; 40 287 291
24. Schmoekel H. G., Weber F. E., Schense J. C. et al. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng: 2005; 89 253 262 (Pubitemid 40288876)
25. Chung Y. I., Ahn K. M., Jeon S. H. et al. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Control Release: 2007; 121 91 99
26. Strobel C., Bormann N., Kadow-Romacker A. et al. Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-component polymeric coating on implants. J Control Release: 2011; 156 37 45
27. Wildemann B., Kandziora F., Krummrey G. et al. Local and controlled release of growth factors (combination of IGF-I and TGF-beta I, and BMP-2 alone) from a polylactide coating of titanium implants does not lead to ectopic bone formation in sheep muscle. J Control Release: 2004; 95 249 256 (Pubitemid 38230039)
28. Dibotermin alfa (InductOs®, Wyeth). In: Pharmazeutische Zeitung online; Govi-Verlag (2003). Im Internet: http://www.pharmazeutische-zeitung.de/ index.php?id=157 Stand: 25.03.2013
29. Eptotermin alfa, Osigraft® (Stryker). In: Pharmazeutische Zeitung online; Govi-Verlag (2007). Im Internet: http://www.pharmazeutische-zeitung.de/ index.php?id=3408 Stand: 25.03.2013
30. Friedlaender G. E., Perry C. R., Cole J. D. et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions: a prospective, randomized clinical trial comparing rhOP-1 with fresh bone autograft. J Bone Joint Surg Am: 2001; 83 01 S151 S158
31. McKee M. D., Schemitsch E. H., Waddell J. P. et al. The effect of human recombinant bone morphogenic protein (rhBMP-7) on the healing of open tibial shaft fractures: results of a multi-center, prospective, randomized clinical trial. In: Proceedings of the 18th Annual Meeting of the Orthopaedic Trauma Association, Oct 11 - 13, Toronto, Ontario, Canada; 2002: 157 - 158.
32. Jones A. L., Buchholz R. W., Bosse M. J. et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am: 2006; 88 1431 1441
33. Calori G. M., D'Avino M., Tagliabue L. et al. An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results. Injury: 2006; 37 43 50
34. Ekrol I., Hajducka C., Court-Brown C. et al. A comparison of RhBMP-7 (OP-1) and autogenous graft for metaphyseal defects after osteotomy of the distal radius. Injury: 2008; 39 73 82
35. Leach J., Bittar R. G. BMP-7 (OP-1) safety in anterior cervical fusion surgery. J Clin Neurosci: 2009; 16 1417 1420
36. Shimer A. L., Oncer F. C., Vaccaro A. R. Spinal reconstruction and bone morphogenetic proteins: open questions. Injury: 2009; 40 32 38
37. Ehnert S., Zhao J., Pscherer S. et al. Transforming growth factor beta1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy? BMC Med: 2012; 10 101
38. Garrison K. R., Shemilt I., Donell S. et al. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev: 2010; 6 CD006950
39. Garrison K. R., Donell S., Ryder J. et al. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol Assess: 2007; 30 1 150
40. Alt V., Heissel A. Economic considerations for the use of recombinant human bone morphogenetic protein-2 in open tibial fractures in Europe: the German model. Curr Med Res Opin: 2006; 22 01 S19 S22 (Pubitemid 44298365)
41. Luo J., Tang M., Huang J. et al. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J Biol Chem: 2010; 285 29588 29598
42. Piek E., Heldin C-H, Ten Dijke P. Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J: 1999; 13 2105 2124
43. Wu N., Zhao Y., Yin Y. et al. Identification and analysis of type II TGF-beta receptors in BMP-9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. Acta Biochim Biophys Sin (Shanghai): 2010; 42 699 708
44. Kloos D. U., Choi C., Wingender E. The TGF-β-Smad network: introducing bioinformatic tools. Trends Genet: 2002; 18 96 103 (Pubitemid 34127809)
45. Miyazawa K., Shinozaki M., Hara T. et al. Two major Smad pathways in TGF-β superfamily signalling. Genes Cells: 2002; 7 1191 1204 (Pubitemid 36024597)
46. Lai C. F., Cheng S. L. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J Biol Chem: 2002; 277 15514 15522
47. Ross S., Hill C. S. How the Smads regulate transcription. Int J Biochem Cell Biol: 2008; 40 383 408 (Pubitemid 351241229)
48. Derynck R., Zhang Y. E. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature: 2003; 425 577 584 (Pubitemid 37280136)
49. Moustakas A. Smad Signalling network. J Cell Sci: 2002; 115 3355 3356 (Pubitemid 34994026)
50. Tang N., Song W. X., Luo J. et al. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med: 2009; 13 2448 2464
51. Javelaud D., Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene: 2005; 24 5742 5750 (Pubitemid 43086134)
52. Zhao Y., Song T., Wang W. et al. P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One: 2012; 7 e43383
53. Nguyen J., Tang S. Y., Nguyen D. et al. Load regulates bone formation and Sclerostin expression through a TGFbeta-dependent mechanism. PLoS One: 2013; 8 e53813
54. McMahon M. S. Bone morphogenic protein 3 signaling in the regulation of osteogenesis. Orthopedics: 2012; 35 920
55. Cook S. D. Preclinical and clinical evaluation of osteogenic Protein 1 (BMP-7) in bony sites. Orthopedics: 1999; 22 669 671 (Pubitemid 29343110)
56. Geesink R. G., Hoefnagels N. H., Bulstra S. K. Osteogenic activity of OP 1 bone morphogenetic protein (BMP 7) in a human fibular defect. J Bone Joint Surg Br: 1999; 81 710 718
57. Chen G., Yang J. Z., Xu H. M. et al. The application of NNB/BMP complex in the treatment of ununited tibia fracture. Orthopedic Journal of China: 2000; 7 758 761
58. Govender S., Csimma C., Genant H. K. et al. Recombinant human bone morphogenetic protein 2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am: 2002; 48 2123 2134 (Pubitemid 35417689)
59. Maniscalco P., Gambera D., Bertone C. et al. Healing of fresh tibial fractures with OP1. A preliminary report. Acta Biomed: 2002; 73 27 33
60. Murphy C. Endo-fin-ally a SARA for BMP receptors. J Cell Sci: 2007; 120 1153 1155
61. Bahamonde M. E., Lyons K. M. BMP3: to be or not to be a BMP. J Bone Joint Surg Am: 2001; 83 56 62